Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PRQR	PROQR THERAPEUTICS NV	$235.89M	-61.20%	-28.10%	-36.59%	3,848.40%	1.05	3.76	100.00%	-231.50%	-222.96%
CELU	CELULARITY INC	$57.39M	-6,372.60%	-57.70%	-128.73%	-65.20%	-5.72	0.25	55.10%	-165.40%	-147.39%
HOWL	WEREWOLF THERAPEUTICS INC	$100.15M	-111.90%	-62.70%	-87.95%	-174.60%	1.23	5.30	N/A	N/A	N/A
BMGL	BASEL MEDICAL GROUP LTD	$33.03M	N/A	N/A	N/A	N/A	1.06	N/A	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$71.32M	-42.60%	-37.80%	-47.37%	-46.40%	0.14	13.84	N/A	N/A	N/A
HSDT	HELIUS MEDICAL TECHNOLOGIES INC	$15.52M	-699.90%	-415.20%	-339.14%	-6,223.70%	0.31	4.32	-89.20%	-7,215.30%	-6,998.98%
XFOR	X4 PHARMACEUTICALS INC	$19.39M	29.30%	8.80%	23.07%	23.40%	4.67	3.70	82.40%	46.50%	76.58%
PMVP	PMV PHARMACEUTICALS INC	$75.33M	-32.50%	-29.60%	-49.22%	-51.80%	0.07	16.75	N/A	N/A	N/A
NEOG	NEOGEN CORP	$1.21B	-41.50%	-27.20%	-32.46%	-69.00%	0.66	3.32	47.10%	-122.10%	-118.65%
COGT	COGENT BIOSCIENCES INC	$1.97B	-120.20%	-89.40%	-131.13%	-158.00%	0.77	4.19	N/A	N/A	N/A
DTIL	PRECISION BIOSCIENCES INC	$56.44M	-35.90%	-15.20%	-18.23%	-54.20%	1.52	6.63	100.00%	-43.00%	-39.94%
ACHV	ACHIEVE LIFE SCIENCES INC	$105.44M	-176.10%	-103.30%	-220.53%	-133.50%	1.66	3.51	N/A	N/A	N/A
NVCT	NUVECTIS PHARMA INC	$150.70M	-150.80%	-94.80%	-130.79%	260.90%	0.60	2.67	N/A	N/A	N/A
KRRO	KORRO BIO INC	$401.93M	-61.50%	-42.90%	-55.90%	-48.60%	0.57	5.98	100.00%	-1,454.50%	-1,452.95%
CLNN	CLENE INC	$59.84M	N/A	-111.70%	-184.73%	-112.90%	-3.59	1.58	80.40%	-10,386.40%	-9,398.60%
MXCT	MAXCYTE INC	$159.91M	-22.10%	-19.10%	-21.50%	-21.30%	0.15	12.40	79.80%	-125.20%	-125.22%
CVKD	CADRENAL THERAPEUTICS INC	$27.47M	-265.40%	-196.40%	-328.17%	937.00%	0.39	3.56	N/A	N/A	N/A
IMRX	IMMUNEERING CORP	$245.15M	-146.30%	-117.20%	-190.76%	-835.10%	0.38	3.70	N/A	N/A	N/A
BIOA	BIOAGE LABS INC	$195.38M	-25.40%	-23.20%	-26.01%	-223.20%	0.09	13.21	100.00%	-2,045.70%	-2,015.64%
IMTX	IMMATICS NV	$961.54M	-15.10%	-11.90%	-13.97%	-21.80%	0.22	8.80	100.00%	-56.80%	-54.78%
RGNX	REGENXBIO INC	$494.08M	-53.30%	-30.80%	-36.03%	-29.10%	0.79	2.94	79.10%	-100.60%	-88.33%
KLTO	KLOTHO NEUROSCIENCES INC	$31.06M	-325.90%	-242.20%	-80.67%	1,735.50%	0.02	135.74	N/A	N/A	N/A
PRTA	PROTHENA CORP PUBLIC LTD CO	$525.38M	-67.90%	-59.50%	-78.99%	-1,191.10%	0.23	5.69	100.00%	-2,929.30%	-2,530.46%
NAOV	NANOVIBRONIX INC	$4.67M	-27.60%	-20.90%	-10.47%	4,110.90%	0.27	1.05	32.10%	-231.90%	-201.24%
GPCR	STRUCTURE THERAPEUTICS INC	$1.46B	-21.30%	-20.30%	-22.96%	-25.90%	0.06	20.48	N/A	N/A	N/A
CDT	CONDUIT PHARMACEUTICALS INC	$2.11M	N/A	-349.40%	-507.47%	33,919.60%	1.26	1.45	N/A	N/A	N/A
HUMA	HUMACYTE INC	$273.98M	N/A	-42.40%	-40.92%	-44.80%	33.25	2.45	56.00%	-7,171.30%	-5,888.75%
ALXO	ALX ONCOLOGY HOLDINGS INC	$93.71M	-115.70%	-84.80%	-150.24%	-107.50%	0.48	4.52	N/A	N/A	N/A
RXST	RXSIGHT INC	$381.17M	-9.50%	-8.50%	-9.12%	-9.50%	0.12	12.68	71.90%	-17.90%	-17.84%
NNVC	NANOVIRICIDES INC	$22.82M	-95.40%	-84.30%	-110.12%	-160.10%	0.14	2.28	N/A	N/A	N/A
SVRA	SAVARA INC	$608.39M	-69.10%	-54.80%	-73.49%	-55.80%	0.36	11.08	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$3.69B	-127.10%	-90.10%	-108.59%	-135.40%	0.46	6.33	N/A	N/A	N/A
ACB	AURORA CANNABIS INC	$350.45M	-5.90%	-3.90%	-3.30%	-4.10%	0.45	2.97	47.80%	-9.10%	-6.28%
HSCS	HEARTSCIENCES INC	$9.06M	-383.30%	-145.30%	-236.86%	-737.30%	1.05	1.47	57.80%	-140,296.50%	-129,710.70%
AEMD	AETHLON MEDICAL INC	$2.00M	-266.20%	-179.40%	-341.67%	-2,964.70%	0.55	2.49	N/A	N/A	N/A
MRUS	MERUS NV	$7.08B	-55.30%	-46.20%	-45.90%	-98.30%	0.16	8.39	100.00%	-555.60%	-587.80%
INKT	MINK THERAPEUTICS INC	$61.96M	N/A	-227.20%	105.57%	291.80%	-1.10	0.15	N/A	N/A	N/A
CBUS	CIBUS INC	$71.05M	-321.40%	-78.70%	-74.47%	-90.60%	3.77	1.78	100.00%	-5,681.60%	-4,975.71%
AMIX	AUTONOMIX MEDICAL INC	$5.45M	-172.90%	-133.40%	-169.41%	1,348.80%	0.28	4.57	N/A	N/A	N/A
ACET	ADICET BIO INC	$68.73M	-59.10%	-50.70%	-67.11%	-93.10%	0.19	9.34	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$289.30M	-62.90%	-54.00%	-80.90%	-71.70%	0.25	5.46	N/A	N/A	N/A
CHRS	COHERUS ONCOLOGY INC	$197.09M	N/A	-26.20%	-97.17%	-41.20%	-3.02	1.22	56.60%	-66.30%	-57.09%
CLDI	CALIDI BIOTHERAPEUTICS INC	$4.08M	N/A	-203.90%	-198.58%	-815.00%	1.12	2.12	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$7.34M	-475.70%	-184.00%	33.59%	-399.30%	0.42	3.41	N/A	N/A	N/A
INMB	INMUNE BIO INC	$56.09M	-171.70%	-132.30%	-190.76%	993.00%	0.31	4.20	100.00%	-111,016.00%	-111,016.00%
ORIC	ORIC PHARMACEUTICALS INC	$1.13B	-51.80%	-47.10%	-41.74%	-64.20%	0.07	16.13	N/A	N/A	N/A
SPRY	ARS PHARMACEUTICALS INC	$960.59M	-21.80%	-15.90%	-17.82%	-17.50%	0.63	6.17	93.70%	-42.70%	-42.49%
MAIA	MAIA BIOTECHNOLOGY INC	$52.79M	-459.70%	-152.90%	-269.45%	445.20%	1.85	2.19	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$261.26M	-37.60%	-28.90%	-38.29%	-37.90%	0.32	5.43	100.00%	-349.20%	-347.02%
TELO	TELOMIR PHARMACEUTICALS INC	$43.26M	-4,593.90%	-1,751.00%	-3,355.08%	3,485.50%	0.72	2.38	N/A	N/A	N/A
OABI	OMNIAB INC	$197.55M	-22.80%	-20.20%	-24.15%	-83.90%	0.13	3.77	98.90%	-275.80%	-296.89%
CTNM	CONTINEUM THERAPEUTICS INC	$331.46M	-29.80%	-28.10%	-32.37%	-32.90%	0.07	24.51	N/A	N/A	N/A
NCNA	NUCANA PLC	$0.00	-581.00%	-204.40%	-274.71%	512.50%	1.20	1.58	N/A	N/A	N/A
NTRB	NUTRIBAND INC	$84.97M	-410.60%	-353.10%	-119.11%	-3,780.30%	0.20	4.79	34.40%	-1,244.40%	-397.54%
ANRO	ALTO NEUROSCIENCE INC	$108.58M	-44.80%	-37.10%	-42.03%	-302.20%	0.28	18.43	N/A	N/A	N/A
TNGX	TANGO THERAPEUTICS INC	$939.04M	-79.70%	-49.30%	-73.48%	-60.90%	0.76	4.75	100.00%	-599.10%	-598.40%
ELDN	ELEDON PHARMACEUTICALS INC	$152.10M	-5.60%	-3.40%	-3.50%	-3.60%	0.77	8.12	N/A	N/A	N/A
CING	CINGULATE INC	$21.05M	-232.20%	-132.10%	-266.57%	-606.30%	1.44	1.52	N/A	N/A	N/A
MRKR	MARKER THERAPEUTICS INC	$11.98M	-114.60%	-90.30%	-138.77%	2,148.70%	0.41	3.45	100.00%	-271.10%	-270.18%
TLRY	TILRAY BRANDS INC	$2.04B	-78.20%	-62.80%	-126.97%	-192.70%	0.39	2.46	29.30%	-266.30%	-277.34%
AVTX	AVALO THERAPEUTICS INC	$171.24M	-48.50%	-35.90%	-41.14%	-3,275.50%	0.21	12.44	242.20%	-10,479.80%	-10,946.03%
AARD	AARDVARK THERAPEUTICS INC	$296.81M	N/A	N/A	N/A	N/A	0.08	14.04	N/A	N/A	N/A
AVBP	ARRIVENT BIOPHARMA INC	$736.73M	-55.50%	-52.10%	-54.82%	-117.00%	0.08	12.74	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$654.77M	-42.60%	-38.60%	-40.79%	-53.10%	0.11	11.09	N/A	N/A	N/A
CATX	PERSPECTIVE THERAPEUTICS INC	$248.78M	-32.50%	-27.70%	-32.51%	-53.00%	0.17	15.09	100.00%	-7,688.50%	-7,838.62%
TIL	INSTIL BIO INC	$124.69M	-54.30%	-33.70%	-35.38%	-24.40%	0.75	14.97	N/A	N/A	N/A
LGVN	LONGEVERON INC	$11.69M	-96.70%	-80.30%	-137.68%	-685.10%	0.32	3.43	78.80%	-901.50%	-894.31%
ADVM	ADVERUM BIOTECHNOLOGIES INC	$96.53M	-332.80%	-113.50%	-283.66%	-121.10%	-5.76	1.54	100.00%	-18,387.40%	-18,387.40%
GRI	GRI BIO INC	$4.98M	-390.20%	-228.00%	-297.74%	764.00%	0.71	2.42	N/A	N/A	N/A
KALA	KALA BIO INC	$13.20M	-369.30%	-65.00%	-119.60%	-154.90%	7.45	1.99	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$20.07M	-62.80%	-33.70%	-51.63%	-60.40%	0.92	0.48	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$2.37B	-34.60%	-32.80%	-37.93%	-40.70%	0.06	16.36	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$150.25M	-43.70%	-39.60%	-51.52%	-48.90%	0.13	9.21	N/A	N/A	N/A
MDAI	SPECTRAL AI INC	$57.47M	N/A	-94.80%	7,785.31%	5,113.20%	-2.75	0.87	45.30%	-52.00%	-50.02%
NVNO	ENVVENO MEDICAL CORP	$18.05M	-57.30%	-53.50%	-68.73%	-64.60%	0.11	11.81	N/A	N/A	N/A
PROF	PROFOUND MEDICAL CORP	$153.27M	-100.20%	-81.60%	-104.27%	-332.40%	0.27	8.53	68.50%	-400.00%	-403.02%
GANX	GAIN THERAPEUTICS INC	$65.07M	-289.10%	-155.10%	-384.64%	1,046.30%	1.66	1.79	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$285.02M	-99.00%	-87.70%	-124.29%	-257.40%	0.22	10.54	N/A	N/A	N/A
ARTL	ARTELO BIOSCIENCES INC	$7.73M	-496.40%	-213.20%	769.82%	538.20%	-4.10	0.39	N/A	N/A	N/A
MRNA	MODERNA INC	$9.86B	-27.50%	-21.20%	-28.21%	-26.80%	0.28	3.93	52.50%	-94.30%	-95.68%
OTLK	OUTLOOK THERAPEUTICS INC	$47.08M	N/A	-199.10%	476.73%	-544.00%	-1.60	0.67	70.80%	-2,885.80%	-2,881.12%
LFWD	LIFEWARD LTD	$11.62M	-137.90%	-90.30%	-181.00%	-408.10%	0.77	2.00	35.60%	-121.80%	-121.63%
TECX	TECTONIC THERAPEUTIC INC	$297.90M	-30.10%	-28.30%	-22.86%	3,469.80%	0.04	25.60	N/A	N/A	N/A
SANA	SANA BIOTECHNOLOGY INC	$841.84M	-115.30%	-54.00%	-76.84%	-120.30%	1.95	2.47	N/A	N/A	N/A
IOVA	IOVANCE BIOTHERAPEUTICS INC	$806.93M	-52.90%	-41.30%	-50.08%	-89.20%	0.30	3.27	20.60%	-161.40%	-161.36%
PCVX	VAXCYTE INC	$4.50B	-16.90%	-15.90%	-17.38%	-19.20%	0.08	11.11	N/A	N/A	N/A
VOR	VOR BIOPHARMA INC	$252.67M	N/A	-1,160.80%	-1,135.37%	-3,792.40%	-1.14	3.49	N/A	N/A	N/A
PLRX	PLIANT THERAPEUTICS INC	$91.47M	-67.60%	-52.50%	-68.28%	-59.60%	0.34	11.03	N/A	N/A	N/A
GBIO	GENERATION BIO CO	$40.28M	-91.10%	-33.70%	-45.24%	-31.80%	2.32	7.51	100.00%	-341.10%	-341.12%
IVF	INVO FERTILITY INC	$3.57M	-603.40%	-98.50%	-392.78%	13,145.90%	6.34	0.11	38.30%	-425.90%	-406.79%
MIST	MILESTONE PHARMACEUTICALS INC	$172.54M	-1,671.20%	-83.00%	-135.89%	-63.40%	-3.67	4.97	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$2.28B	43.30%	40.10%	49.57%	47.20%	0.07	14.48	88.20%	1,590.40%	1,698.66%
IMMX	IMMIX BIOPHARMA INC	$57.98M	-130.00%	-86.30%	-197.03%	1,814.20%	1.07	1.80	N/A	N/A	N/A
ABSI	ABSCI CORP	$444.08M	-60.20%	-50.90%	-63.13%	-110.20%	0.21	4.39	100.00%	-2,737.90%	-2,724.43%
MSPR	MSP RECOVERY INC	$1.84M	-1,748.80%	-28.40%	-10.59%	171.80%	-11.00	0.01	-3,573.50%	-4,375.60%	-885.55%
KALV	KALVISTA PHARMACEUTICALS INC	$616.89M	-195.60%	-90.00%	-106.27%	-232.10%	4.28	5.37	58.60%	-14,242.60%	-13,200.77%
RXRX	RECURSION PHARMACEUTICALS INC	$2.13B	-76.10%	-54.30%	-57.02%	-278.70%	0.42	3.58	-3.50%	-1,004.90%	-1,004.89%
ALZN	ALZAMEND NEURO INC	$7.41M	-166.80%	-137.00%	-116.68%	4,925.40%	0.18	6.03	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$8.61B	-41.80%	-35.60%	-36.16%	-43.60%	0.30	11.79	N/A	N/A	N/A
OSUR	ORASURE TECHNOLOGIES INC	$232.58M	-12.70%	-11.10%	-11.93%	-36.10%	0.17	7.12	40.50%	-36.80%	-34.69%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	634	+1.11%	+1.63%	+8.26%	-29.19%	-106.49x	4.77x	-113.22%	-7.27%	-11.64%	+72.95%	Strong Buy
Diagnostics & Research	56	+0.02%	-2.47%	-3.27%	-17.42%	20.31x	3.68x	-2.84%	+7.18%	+15.71%	+12.49%	Buy
Drug Manufacturers - General	19	+0.40%	-2.01%	-0.30%	-10.52%	37.13x	5.94x	+60.35%	+10.38%	+17.86%	+44.87%	Buy
Drug Manufacturers - Specialty & Generic	76	-0.73%	-2.78%	-1.16%	-17.44%	-34.94x	2.21x	+11.10%	+4.22%	+9.47%	+36.51%	Buy
Healthcare Plans	11	+0.30%	+1.05%	-0.09%	-32.06%	14.70x	2.04x	+15.84%	+4.97%	+11.53%	+15.72%	Buy
Health Information Services	53	+0.68%	-0.84%	+1.04%	-53.39%	77.94x	4.23x	+8.42%	+5.33%	+9.22%	+26.25%	Strong Buy
Medical Care Facilities	47	-0.63%	+1.73%	+2.31%	-28.10%	16.56x	5.02x	-187.19%	+6.89%	+15.31%	+14.05%	Buy
Medical Devices	142	-0.10%	-3.04%	-5.16%	-29.50%	29.79x	3.92x	+13.90%	+8.58%	+10.11%	+32.38%	Strong Buy
Medical Distribution	10	+0.23%	+7.25%	+7.77%	+39.80%	28.84x	312.62x	-10.56%	+3.08%	+19.02%	+10.88%	Buy
Medical Instruments & Supplies	55	-0.14%	-2.16%	-3.88%	-63.65%	29.71x	3.28x	+10.49%	+8.41%	+11.17%	+28.18%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #1 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -0.71% over the past year, overperforming other healthcare stocks by 31 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 32.14% from Embecta's current stock price of $14.00.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #2 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: C, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 30, which is 5 points higher than the healthcare sector average of 25. It passed 10 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 70.58% over the past year, overperforming other healthcare stocks by 102 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $7.92, a downside of -10.74% from Aveanna Healthcare Holdings's current stock price of $8.87.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 79.03% over the past year, overperforming other healthcare stocks by 111 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 77.87% from Theravance Biopharma's current stock price of $14.43.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.71%, which is 13 percentage points higher than the healthcare sector average of 2.09%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 8.62%, which is 7 percentage points higher than the healthcare sector average of 2.09%.

Cryo Cell International's dividend payout ratio of -2,166.7% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.45%, which is 5 percentage points higher than the healthcare sector average of 2.09%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.36% in the last day, and down -0.25% over the last week. Enanta Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 91.9% yesterday.

Enanta Pharmaceuticals shares are trading higher after the company reported topline results from its Phase 2b study of Zelicapavir for RSV in high-risk adults.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -30.9% in the past year. It has overperformed other stocks in the healthcare sector by 1 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -0.71% in the past year. It has overperformed other stocks in the healthcare sector by 31 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 98.04% in the past year. It has overperformed other stocks in the healthcare sector by 130 percentage points.

Are healthcare stocks a good buy now?

51.99% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.02% over the next year.

5.18% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.59% of healthcare stocks are rated B (Buy), 46.94% are rated C (Hold), 23.88% are rated D (Sell), and 11.41% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.18x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Embecta (NASDAQ:EMBC)

2. Aveanna Healthcare Holdings (NASDAQ:AVAH)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Embecta (NASDAQ:EMBC)

2. Aveanna Healthcare Holdings (NASDAQ:AVAH)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.